Hepatitis C virus modulates signal peptide peptidase to alter host protein processing
暂无分享,去创建一个
D. Standley | Masahiro Yamamoto | K. Koike | T. Kodama | T. Takehara | Y. Matsuura | Y. Maeda | T. Okamoto | K. Moriishi | Sachiyo Yoshio | T. Kanto | K. Moriya | Yu Takahashi | Y. Sakai | Tatsuya Suzuki | Junki Hirano | Y. Ono | David Virya Chen | Y. Itoh | Saori Haga | He Zhang | L. Songling | Hiroko Oomori | Y. Takahashi
[1] Shaohui Wang,et al. Absence of Signal Peptide Peptidase, an Essential Herpes Simplex Virus 1 Glycoprotein K Binding Partner, Reduces Virus Infectivity In Vivo , 2019, Journal of Virology.
[2] T. Horii,et al. Characterization of SPP inhibitors suppressing propagation of HCV and protozoa , 2017, Proceedings of the National Academy of Sciences.
[3] J. Kao,et al. Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants. , 2017, Best practice & research. Clinical gastroenterology.
[4] C. Strassburg,et al. Increased peripheral CD4+ regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C. , 2017, Journal of hepatology.
[5] L. Bolondi,et al. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. , 2016, Journal of hepatology.
[6] M. Manns,et al. Nonreversible MAIT cell‐dysfunction in chronic hepatitis C virus infection despite successful interferon‐free therapy , 2016, European journal of immunology.
[7] R. Elliott,et al. Bunyamwera orthobunyavirus glycoprotein precursor is processed by cellular signal peptidase and signal peptide peptidase , 2016, Proceedings of the National Academy of Sciences.
[8] G. Dougan,et al. Genetic dissection of mammalian ERAD through comparative haploid and CRISPR forward genetic screens , 2016, Nature Communications.
[9] Toru Okamoto,et al. TRC8-dependent degradation of hepatitis C virus immature core protein regulates viral propagation and pathogenesis , 2016, Nature Communications.
[10] S. Akira,et al. p62 Plays a Specific Role in Interferon-γ-Induced Presentation of a Toxoplasma Vacuolar Antigen. , 2015, Cell reports.
[11] H. Fuchino,et al. Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes* , 2015, The Journal of Biological Chemistry.
[12] D. Langosch,et al. Signal peptide peptidase functions in ERAD to cleave the unfolded protein response regulator XBP1u , 2014, The EMBO journal.
[13] M. Heim,et al. Innate and adaptive immune responses in HCV infections. , 2014, Journal of hepatology.
[14] N. Enomoto,et al. Hallmarks of Hepatitis C Virus in Equine Hepacivirus , 2014, Journal of Virology.
[15] G. Dougan,et al. TMEM129 is a Derlin-1 associated ERAD E3 ligase essential for virus-induced degradation of MHC-I , 2014, Proceedings of the National Academy of Sciences.
[16] Neville E. Sanjana,et al. Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.
[17] S. Bloor,et al. Cleavage by signal peptide peptidase is required for the degradation of selected tail-anchored proteins , 2014, The Journal of cell biology.
[18] Yoshiharu Matsuura,et al. Binding of HSV-1 Glycoprotein K (gK) to Signal Peptide Peptidase (SPP) Is Required for Virus Infectivity , 2014, PloS one.
[19] R. Colbert,et al. HLA-B27 misfolding and ankylosing spondylitis. , 2014, Molecular immunology.
[20] P. Lehner,et al. MHC class I molecules are preferentially ubiquitinated on endoplasmic reticulum luminal residues during HRD1 ubiquitin E3 ligase-mediated dislocation , 2013, Proceedings of the National Academy of Sciences.
[21] Ralf Bartenschlager,et al. The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection , 2013, Nature Reviews Microbiology.
[22] H. Wedemeyer,et al. Natural history of acute and chronic hepatitis C. , 2012, Best practice & research. Clinical gastroenterology.
[23] Wei Li,et al. Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice. , 2011, The Journal of clinical investigation.
[24] A. Muir,et al. Direct-acting antiviral medications for chronic hepatitis C virus infection. , 2011, Gastroenterology & hepatology.
[25] P. Lehner,et al. HRD1 and UBE2J1 target misfolded MHC class I heavy chains for endoplasmic reticulum-associated degradation , 2011, Proceedings of the National Academy of Sciences.
[26] P. Bates,et al. Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein , 2010, PLoS pathogens.
[27] Mair E. M. Thomas,et al. The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER , 2009, The Journal of cell biology.
[28] Bindu Nanduri,et al. Bovine viral diarrhea virus infection affects the expression of proteins related to professional antigen presentation in bovine monocytes. , 2009, Biochimica et biophysica acta.
[29] M. Takeda,et al. Intramembrane Processing by Signal Peptide Peptidase Regulates the Membrane Localization of Hepatitis C Virus Core Protein and Viral Propagation , 2008, Journal of Virology.
[30] S. Emerson,et al. Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus , 2008, Proceedings of the National Academy of Sciences.
[31] Y. Matsuura,et al. Hepatitis C virus core protein: its coordinate roles with PA28gamma in metabolic abnormality and carcinogenicity in the liver. , 2008, The international journal of biochemistry & cell biology.
[32] M. Knittler,et al. Molecular Architecture of the TAP-Associated MHC Class I Peptide-Loading Complex1 , 2007, The Journal of Immunology.
[33] E. Wiertz,et al. Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3 , 2007, The Journal of cell biology.
[34] R. Guarisco,et al. Extrahepatic manifestations of chronic HCV infection. , 2007, Journal of gastrointestinal and liver diseases : JGLD.
[35] P. Arosio,et al. Comparative study between Hfe‐/‐ and β2m‐/‐ mice: progression with age of iron status and liver pathology , 2006, International journal of experimental pathology.
[36] H. Ploegh,et al. Signal peptide peptidase is required for dislocation from the endoplasmic reticulum , 2006, Nature.
[37] David B. Williams,et al. Functions of ERp57 in the Folding and Assembly of Major Histocompatibility Complex Class I Molecules* , 2006, Journal of Biological Chemistry.
[38] Stephen L. Chen,et al. The Natural History of Hepatitis C Virus (HCV) Infection , 2006, International journal of medical sciences.
[39] Lewis L Lanier,et al. NK cell recognition. , 2005, Annual review of immunology.
[40] Tracey M. Filzen,et al. HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail , 2004, The Journal of cell biology.
[41] A. Mathieu,et al. [The role of HLA-B27 molecules in the pathogenesis of ankylosing spondylitis]. , 2011, Reumatismo.
[42] P. Lapinski,et al. Calreticulin recognizes misfolded HLA-A2 heavy chains , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[43] V. Engelhard. Faculty Opinions recommendation of Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes. , 2002 .
[44] B. Martoglio,et al. Intramembrane Proteolysis of Signal Peptides: An Essential Step in the Generation of HLA-E Epitopes1 , 2001, The Journal of Immunology.
[45] P. Stevenson,et al. MHC class I ubiquitination by a viral PHD/LAP finger protein. , 2001, Immunity.
[46] R. Pettersson,et al. Distinct differences in association of MHC class I with endoplasmic reticulum proteins in wild-type, and beta 2-microglobulin- and TAP-deficient cell lines. , 2001, International immunology.
[47] K. Lindsten,et al. Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[48] J. Yewdell,et al. Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. , 1999, Journal of immunology.
[49] F. Li,et al. The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[50] M. Mann,et al. ER‐60, a chaperone with thiol‐dependent reductase activity involved in MHC class I assembly , 1998, The EMBO journal.
[51] B. Martoglio,et al. Signal peptide fragments of preprolactin and HIV‐1 p‐gp160 interact with calmodulin , 1997, The EMBO journal.
[52] W. Sly,et al. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[53] K Koike,et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. , 1997, The Journal of general virology.
[54] P. Cresswell,et al. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[55] P. A. Peterson,et al. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. , 1997, Immunity.
[56] P. Cresswell,et al. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[57] Stefan Imreh,et al. Inhibition of antigen processing by the internal repeat region of the EpsteinBarr virus nuclear antigen-1 , 1995, Nature.
[58] P. A. Peterson,et al. A viral inhibitor of peptide transporters for antigen presentation , 1995, Nature.
[59] M. Brandon,et al. Lymphocyte subpopulations in the blood of sheep persistently infected with border disease virus. , 1989, Clinical and experimental immunology.